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Abstract
Background:  Previous studies have suggested that both underdiagnosis and overdiagnosis
routinely occur in ADHD and hyperkinesis (hyperkinetic disorders). England has introduced
governmental guidelines for these disorders' detection and treatment, but there has been no study
on clinical diagnostic accuracy under such a regime.
Methods: All open cases in three Child and Adolescent Mental Health Services (CAMHS) in the
South East of England were assessed for accuracy in the detection of hyperkinetic disorders, using
a two-stage process employing the Strengths and Difficulties Questionnaire (SDQ) for screening,
with the cut-off between "unlikely" and "possible" as the threshold for identification, and the
Development And Well-Being Assessment (DAWBA) as a valid and reliable standard.
Results: 502 cases were collected. Their mean age 11 years (std dev 3 y); 59% were clinically
diagnosed as having a hyperkinetic disorder including ADHD. Clinicians had missed two diagnoses
of hyperkinesis and six of ADHD. The only 'false positive' case was one that had become
asymptomatic on appropriate treatment.
Conclusion: The identification of children with hyperkinetic disorders by three ordinary English
CAMHS teams appears now to be generally consistent with that of a validated, standardised
assessment. It seems likely that this reflects the impact of Governmental guidelines, which could
therefore be an appropriate tool to ensure consistent accurate diagnosis internationally.
Background
Disorders involving attention, overactivity and impulsiv-
ity (hyperkinetic disorders) are now recognised as the
commonest neurodevelopmental presentation in child-
hood [1]. Despite this, and the availability of effective
treatments [2] there is lack of clarity over detection and
diagnosis. The diagnostic systems of ICD-10 [3] and DSM
IV [4] employ different diagnostic criteria, defining
Hyperkinesis and Attention Deficit Hyperactivity Disorder
(ADHD) respectively. The United States (US) and other
countries that primarily use DSM IV report variability in
detection that suggests both overdetection and underde-
tection, measured either directly or through using stimu-
lant medication prescription as a proxy [5-8]; the United
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Kingdom (UK), which primarily uses ICD-10, reports
underdetection only [9-11] despite contemporaneous
international professional guidelines [e.g., [12]].
In England since 2000, the Government has intervened in
this controversy by introducing practice guidelines for the
detection of hyperkinetic disorders by the National
Health Service (NHS) in addition to those provided by
professional bodies, focussing primarily on secondary
care [13], but there has been no investigation of diagnos-
tic accuracy since their introduction. Accordingly, we
assessed secondary care clinical diagnoses of ADHD and
hyperkinesis against the standard set by the Development
And Well-Being Assessment (DAWBA) [14], a well-vali-
dated instrument which was employed in the UK




East Berkshire is served by three secondary care Child and
Adolescent Mental Health Service (CAMHS) teams, cover-
ing a total child (0–16) population of approximately
85,000. Each team had identical referral policies within
the specified age-range, and diagnosed children according
to NICE guidelines, which included assessment in multi-
ple domains supported by questionnaires. Both ICD-10
and DSM IV diagnoses were used by all teams. All teams
used the Strengths and Difficulties Questionnaire (SDQ)
[16], as the teams are part of the CAMHS Outcome
Research Consortium (CORC) [17]. The SDQ provides a
probabilistic assessment of the likelihood of hyperkinetic
disorders, based on UK population norms. Assessment
policies differed slightly between the teams: one team rou-
tinely screened all referrals using the SDQ as a preliminary
assessment of psychopathology; the other two teams
employed the same questionnaire to detect ADHD before
clinic assessment, if hyperkinetic disorders were suspected
from the referral letter. Thus, in one team the SDQ
informed all diagnoses made in the team, but in the other
two the SDQ only informed the diagnoses of cases already
suspected of having ADHD. Between October 2004 and
July 2005 all cases from each team were reviewed, and
included if: an assessment had been completed; the case
was currently open to the team; and there was recorded
evidence of activity in the case-file in the preceding 12
months. The child (0–16) community population served
by each clinic was also enumerated, to allow estimation of
predicted community prevalence as an indicator of sam-
ple representativeness.
Reference standard & clinical diagnoses
The standard for ADHD diagnosis was that of the Devel-
opment and Well-Being Assessment (DAWBA) [14,18],
which had both sufficient validity and reliability, and two
additional advantages for this study. First, the SDQ is an
integral part of the DAWBA (providing an initial screen
for caseness and diagnostic type), and so can be used for
screening in the context of ordinary clinic activity; sec-
ondly, the DAWBA is the instrument employed by the
National Statistics Mental Health of Children survey [11]
and so ensures a close relationship with nationally
accepted assessments. The DAWBA generates both ICD-10
and DSM IV diagnoses of hyperkinetic disorders. The
DAWBA consists of highly structured questions closely
related to the diagnostic criteria in both ICD-10 and DSM
IV, supplemented with descriptions of problem areas in
the informant's own words (parent, teacher or young per-
son if aged 11 plus). A series of prompts explored these
problem areas. Data from all informants and both the
structured and qualitative parts of the DAWBA can be
combined by trained clinical raters to assign diagnoses.
Alternatively the data from the structured questions pro-
vides computer predictions about the likelihood of diag-
noses based on data from several large national surveys
that used the DAWBA (refs). DMF was the trained rater,
having previously trained and rated cases on one of the
national surveys. DMF trained SD, a psychology graduate,
as the interviewer. DMF was blind to all other case-related
data (i.e., clinic diagnosis and case-note information)
when making ratings. As clinic notes frequently made no
mention of the diagnostic system used in making the diag-
nosis, a single category of "hyperkinetic disorders" was
used to identify all clinical diagnoses made. Clinical case-
note diagnoses were coded by SD into six categories:
hyperkinetic disorders; emotional disorders; non-hyper-
active behaviour disorders; mixed disorders of behaviour
and emotions; other disorders; and no disorder.
Data collection
SDQ scores from all cases were collected; if a SDQ was not
available from the file one was requested from the par-
ents. If multiple SDQ informants were available, their
scores were combined to produce the prediction; other-
wise single SDQ scores, from either parent or teacher,
were used. The earliest SDQ was used, if collection had
occurred at several time points. As all teams used SDQs as
the preliminary screen for hyperkinetic disorders, this pro-
tocol ensured that (except for cases transferred from else-
where, already diagnosed) the SDQ used in the study was
collected prior to clinical diagnosis of a hyperkinetic dis-
order. The resulting SDQ predictions for hyperkinetic dis-
orders were compared with case-note files by SD. Cases
were classified as concordant or discordant for hyperki-
netic disorders according to table 1.
The cut-offs for discordancy chosen were based on the
"unlikely" SDQ diagnostic prediction for hyperkinetic dis-
orders being associated with a complete absence of such
cases in its validation study [19], while a similar absenceChild and Adolescent Psychiatry and Mental Health 2008, 2:32 http://www.capmh.com/content/2/1/32
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of clinical over-diagnosis with respect to the DAWBA was
found in the ONS child psychiatric morbidity study [11].
All discordant case identified were invited for interview
using the DAWBA, as were cases where previous attempts
to obtain an SDQ had been unsuccessful, in a final
attempt to obtain SDQ scores.
In routine assessment, clinicians would routinely seek
confirmation of the pervasiveness of difficulties from
teachers before making a diagnosis of ADHD or hyperki-
netic disorder. However, if not previously present in the
file, teacher-rated SDQs could not be obtained as permis-
sion to contact school was not routinely available; DAW-
BAs were likewise limited to parent interviews only.
Ethics
On submission to the Local Resarch Ethics Committee, it
was determined that the study should be managed under
local audit protocols. However, it was agreed with the
Local Research Ethics Committee that any discordant
cases, where the DAWBA result disagreed with the clini-
cian, would be fed back to the patient's clinician, who
would have responsibility for discussing the finding with
the patient and their family.
Analysis
Diagnostic concordance between clinic diagnoses and the
DAWBA were explored by descriptive statistics and cross-
tabulations (see below); these analyses were conducted
within the R statistical environment version 2.6.1 [20,21].
Community prevalence rates were estimated using a hier-
archical random effects model, to take into account likely
local differences in presentation between clinics, using
WinBUGS 1.4.1 [22].
Results
502 cases met the inclusion criteria, and 498 had diag-
noses recorded in the files. The mean age was 11 years
(s.d. 3 y) and 77% were male. Three percent (16/498) of
case-files recorded no disorder, 19% (94/498) emotional
disorders, 5% (24/498) non-hyperactive behaviour disor-
ders, 59% (294/498) hyperkinetic disorders (including
hyperkinetic conduct disorder), 9% (47/498) mixed dis-
orders of conduct and emotion, and 20% (98/498) other
disorders. Overall, 15% (74/498) met criteria for more
than one diagnostic category. The numbers of cases clini-
cally identified as hyperkinetic disorders, concordant and
discordant cases, results of DAWBA interviews, response
rates and data missing at each stage in the data collection
process are set out in figure 1. Of those cases who did not
complete DAWBA interviews or SDQs, the clinicians
responsible for the case considered contact for DAWBA
interview inadvisable in 2 cases; the families refused to
agree to interview in 3 cases; and the families did not
attend for interview in 5 cases.
Comparing clinic diagnoses of hyperkinetic disorders
against DAWBA diagnoses of ADHD identified 6 cases of
DAWBA-identified ADHD not recognised by clinicians:
five of these were considered to be emotional disorders;
one was classified as 'other'. Only two cases of DAWBA-
identified Hyperkinesis were not clinically identified: one
emotional disorder and one 'other.' Clinicians only iden-
tified one case as hyperactive that the DAWBA did not
detect. This child was taking stimulant medication when
the DAWBA assessment was done. Overall, clinicians cor-
rectly discriminated more than 98% of cases with hyperk-
inetic disorders.
Among the discordant cases, clinicians significantly
underdiagnosed hyperkinetic disorders relative to the
DAWBA (see figure 1: 6/6 cases underdiagnosed vs. 1/26
overdiagnosed, Fisher's exact test p < 0.001) while the
SDQ overidentified hyperkinetic disorders relative to cli-
nicians: (40/328 cases overidentified vs. 2/172 underi-
dentified, Fisher's exact test p < 0.001).
The three teams (B, M, and F) each contributed 198, 106,
and 198 cases to the sample, with 11, 10, and 11 discord-
ant cases respectively (Fisher's exact test, p = .58). As DMF
was also one of the consultant psychiatrists responsible
for making clinical diagnoses in one of the teams, bias
could have been introduced if DMF recognised his own
cases among the DAWBAs rated. However, this would
have applied to DMF's team only, and in practice the non-
agreed diagnoses for discordant cases were also distrib-
uted evenly between the three teams (2/11 (DMF's team),
1/10, 4/11; Fisher's exact test, p = .44).
Table 1: Classification of agreement between strengths and difficulties questionnaire (SDQ) and case-note assessment of open cases†
Case-note assessment SDQ prediction Hyperkinetic disorders
Unlikely Possible Probable
Hyperkinetic disorders identified Discordant Concordant Concordant
Hyperkinetic disorders* not identified Concordant Discordant Discordant
*includes uncertain cases
† See figure 1 for numbers of classified casesChild and Adolescent Psychiatry and Mental Health 2008, 2:32 http://www.capmh.com/content/2/1/32
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Flow chart of recruitment and assignation of patients Figure 1
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Using cases confirmed against the study standard, the esti-
mated median community prevalence rate for hyperki-
netic disorders was 0.54% (95% interquantile range
0.23%–1.2%).
Discussion
This study suggests that the current diagnosis of hyperki-
netic disorders by UK secondary care teams is similar to
that of a well-validated, standardised measure. This is
markedly different to the previous research reviewed in
the Introduction, and is consistent with the proposition
that the introduction of governmental guidelines may
have improved clinical practice in this area. While well-
validated standardised measures for hyperkinetic disor-
ders have been available for some time [23] their use in
support of routine clinical diagnosis has become general
in the UK only since being recommended by NICE in
2001. Similarly, in the 1980s both ICD-9 and DSM III
provided detailed diagnostic criteria for hyperkinetic dis-
orders sufficient to ensure reasonable diagnostic reliabil-
ity in research settings, but which did not translate into
accurate clinical practice [9] despite mounting public con-
cern and publicity. Research published elsewhere [24]
confirms that the introduction of NICE guidance was fol-
lowed by an increase in the rate of treatment for hyperki-
netic disorders; this paper indicates that the increase in
rate was in well-diagnosed cases.
The SDQ contributed to both clinical and study diag-
noses, so the study does not address the accuracy of clinic
diagnoses independent of SDQ usage: this limitation was
accepted as the use of validated questionnaires such as the
SDQ in supporting diagnoses are specifically recom-
mended in NICE guidance, and so are included in the cur-
rent diagnostic clinical standard. Failure to use them may
well contribute to underdetection [10]. The discordant
cases show that, despite concerns, questionnaire cut-offs
have not inappropriately replaced clinical judgement in
diagnosing ADHD.
Though the confidence interval is quite wide, the estimate
of community prevalence is consistent with the propor-
tion of children with hyperkinetic disorders being referred
to secondary care nationally [11], supporting the sample's
representativeness.
Due both to the 2-stage design, and its inability to access
school-related data for the DAWBA, the full standard was
not applied to individual cases. This introduces two
potential artefacts, which offer alternative explanations of
the results. Firstly, the high levels of agreement in con-
cordant cases could reflect joint over-identification by the
clinician and the SDQ. This follows from the conflation of
the 'possible' and 'probable' SDQ categories in defining
concordant and discordant cases, as parental question-
naires' estimates are known to be approximately twice the
true number of cases in the clinic setting [10,25]. Alterna-
tively, the agreement between DAWBA and clinician in
the discordant cases could be because of joint under-iden-
tification of hyperactive cases by both clinicians and the
parent-only DAWBA, as Ford et al [26] found that the sen-
sitivity of the DAWBA to ADHD was significantly reduced
in the absence of school data. However, both seem
unlikely. In the first case, the relatively insensitive parent-
only DAWBA is both less sensitive to hyperkinetic disor-
ders than the SDQ, and more sensitive than clinicians. It
is inconceivable that clinicians could both be less sensi-
tive to hyperkinetic disorders than the DAWBA, and also
oversensitive to approximately the same extent as the
SDQ. In the second, alternative case, the initial detection
of "missed" hyperkinetic disorders in our study was by the
SDQ, and the cutoff (at 'possible' hyperkinetic disorders)
has been found to miss no cases [16,27]. While 30 of the
32 discordant cases were SDQ positive for hyperkinetic
disorders in the absence of a clinical diagnosis, this total
represents only 6% of the sample, and estimates by paren-
tal questionnaires such as the SDQ are known to approx-
imately double the true number of cases in the clinic
setting [10,25]. The available margin for error is thus
small, and applying Ford et al's figures of a 42% reduction
in sensitivity suggests that only 1–2% of the total sample
is likely to have been misdiagnosed by the DAWBA for
this reason. This error is very much less than that reported
between clinical and standardised assessments in the
studies reviewed in the introduction, and so does not
invalidate the main conclusion of the study. Instead, the
study found evidence of considerable SDQ oversensitivity
in relation to clinician diagnosis, which would not be the
case if the agreement resulted from equivalent underde-
tection.
Overall, the results suggest that disagreements between
the DAWBA standard and clinician diagnoses are most
likely to result from clinician underdetection of hyperki-
netic disorders, which is consistent with previous commu-
nity [11] and clinic [10] samples before or after the
introduction of Government guidelines. While the very
high levels of agreement between the SDQ and clinician
diagnoses are greater than those found in a validation of
the SDQ predictive categories [27], this can be understood
by the study's use of looser clinical diagnostic criteria,
using, as shown in table 1 only 4 (vs. 9) discriminatory
categories to determine concordance, and the SDQ scores
contributing to the clinical diagnostic process in many
cases – this last being, of course, a consequence of adher-
ence to NICE guidance.
As two teams initiated SDQ collection only if a hyperki-
netic disorder was already suspected, a comparison
between all three teams would reconsider Foreman et al'sChild and Adolescent Psychiatry and Mental Health 2008, 2:32 http://www.capmh.com/content/2/1/32
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2001 [10] finding that screening was needed to increase
awareness of hyperkinetic disorder under the changed
conditions of NICE guidelines, 4–5 years on. The lack of
any significant difference between the teams is consistent
with the guidance acting to appropriately increase diag-
nostic awareness since its introduction in 2001. Unfortu-
nately, the study could not access closed cases, so any
improvement in awareness must be inferred, rather than
directly demonstrated.
Conclusion
It seems that parents and children routinely attending sec-
ondary care clinics in the UK receive diagnoses very simi-
lar to those made using agreed, explicit standards, and so
can take confidence in diagnoses of hyperkinetic disorders
given to them. As this was found in services making use of
governmental guidelines, the use of such guidelines
should be explored in settings where similar levels of diag-
nostic agreement have not been achieved. A case can also
be made for making structured, normed assessments like
the DAWBA a routine part of the clinical assessment for
hyperkinetic disorders in CAMHS, as some degree of clini-
cian underdetection in secondary care still seems likely.
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